Bjørn Naume

13.0k total citations · 1 hit paper
134 papers, 6.7k citations indexed

About

Bjørn Naume is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Bjørn Naume has authored 134 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Oncology, 68 papers in Cancer Research and 46 papers in Molecular Biology. Recurrent topics in Bjørn Naume's work include Cancer Cells and Metastasis (43 papers), Breast Cancer Treatment Studies (39 papers) and Cancer Genomics and Diagnostics (30 papers). Bjørn Naume is often cited by papers focused on Cancer Cells and Metastasis (43 papers), Breast Cancer Treatment Studies (39 papers) and Cancer Genomics and Diagnostics (30 papers). Bjørn Naume collaborates with scholars based in Norway, United States and Sweden. Bjørn Naume's co-authors include Elin Borgen, Anne‐Lise Børresen‐Dale, Terje Espevik, Vessela N. Kristensen, Gunnar Kvalheim, Hege G. Russnes, Gro Wiedswang, Thérese Sørlie, Rolf Kåresen and Silje Nord and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Bjørn Naume

129 papers receiving 6.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Allele-specific copy number analysis of tumors

2010 635 citations Silje Nord, Ole Christian Lingjærde et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bjørn Naume Norway	45	3.4k	3.1k	2.5k	1.1k	862	134	6.7k
Anne F. Schott United States	32	4.4k 1.3×	2.5k 0.8×	2.4k 1.0×	898 0.8×	952 1.1×	92	7.0k
Aurelia Noske Germany	38	3.2k 0.9×	1.9k 0.6×	3.2k 1.3×	705 0.7×	950 1.1×	102	6.8k
Peter Vermeulen Belgium	42	3.2k 0.9×	2.7k 0.9×	3.1k 1.2×	1.1k 1.1×	605 0.7×	142	6.6k
Steven Van Laere Belgium	45	2.7k 0.8×	2.5k 0.8×	2.6k 1.0×	968 0.9×	494 0.6×	161	5.6k
Nils Brünner Denmark	56	4.1k 1.2×	5.0k 1.6×	4.0k 1.6×	917 0.9×	770 0.9×	238	9.9k
Daniele Generali Italy	42	3.1k 0.9×	2.1k 0.7×	2.5k 1.0×	1.7k 1.6×	475 0.6×	232	6.2k
Mark Basik Canada	41	2.8k 0.8×	2.9k 0.9×	3.5k 1.4×	1.0k 1.0×	774 0.9×	142	7.2k
Hirotaka Iwase Japan	47	3.0k 0.9×	2.2k 0.7×	2.9k 1.2×	840 0.8×	447 0.5×	210	6.2k
Carmen Criscitiello Italy	44	4.4k 1.3×	2.2k 0.7×	1.5k 0.6×	1.5k 1.4×	999 1.2×	202	7.0k
Kunwei Shen China	37	2.7k 0.8×	2.2k 0.7×	1.6k 0.6×	914 0.9×	573 0.7×	231	5.2k

Countries citing papers authored by Bjørn Naume

Since Specialization

Citations

This map shows the geographic impact of Bjørn Naume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjørn Naume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjørn Naume more than expected).

Fields of papers citing papers by Bjørn Naume

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjørn Naume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjørn Naume. The network helps show where Bjørn Naume may publish in the future.

Co-authorship network of co-authors of Bjørn Naume

This figure shows the co-authorship network connecting the top 25 collaborators of Bjørn Naume. A scholar is included among the top collaborators of Bjørn Naume based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjørn Naume. Bjørn Naume is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tekpli, Xavier, Ole Christian Lingjærde, Hege G. Russnes, et al.. (2025). High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis. Communications Medicine. 5(1). 234–234.

Holm, Kristian, Corinna Bang, Ole Christian Lingjærde, et al.. (2024). Gut microbiota diversity is prognostic and associated with benefit from chemo‐immunotherapy in metastatic triple‐negative breast cancer. Molecular Oncology. 19(4). 1229–1243. 9 indexed citations

Gilje, Bjørnar, Andrea Gombos, Ragnhild Sørum Falk, et al.. (2024). Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial. Journal for ImmunoTherapy of Cancer. 12(1). e007990–e007990. 8 indexed citations

Engan, Harald, et al.. (2023). Late effects after breast cancer treatment. Tidsskrift for Den norske legeforening. 143(11). 2 indexed citations

Nilssen, Yngvar, Odd Terje Brustugun, Morten Eriksen, et al.. (2020). Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016. BMC Cancer. 20(1). 488–488. 15 indexed citations

Lien, Tonje G., Xavier Tekpli, Laxmi Silwal‐Pandit, et al.. (2020). Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer. International Journal of Cancer. 147(9). 2515–2525. 14 indexed citations

Nilssen, Yngvar, Odd Terje Brustugun, Morten Eriksen, et al.. (2019). Decreasing waiting time for treatment before and during implementation of cancer patient pathways in Norway. Cancer Epidemiology. 61. 59–69. 22 indexed citations

Westgaard, Arne, et al.. (2017). Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4). Tumor Biology. 39(6). 3726132343–3726132343. 7 indexed citations

Brunborg, Cathrine, Anne Waage, Harald Hugenschmidt, et al.. (2017). Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases. Annals of Surgical Oncology. 24(8). 2113–2121. 18 indexed citations

10.

Panda, Anshuman, Surendra Kumar, Michael Seiler, et al.. (2017). Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma. Scientific Reports. 7(1). 5568–5568. 32 indexed citations

11.

Gingras, Isabelle, Eileen Holmes, Evandro de Azambuja, et al.. (2016). Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial. JNCI Journal of the National Cancer Institute. 109(8). 19 indexed citations

12.

Sahlberg, Kristine Kleivi, Giulia Bottai, Bjørn Naume, et al.. (2014). A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients. Clinical Cancer Research. 21(5). 1207–1214. 186 indexed citations

13.

Fleischer, Thomas, Arnoldo Frigessi, Kevin C. Johnson, et al.. (2014). Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome biology. 15(8). 435–435. 139 indexed citations

14.

Flamen, Patrick, Robert Coleman, Bjørn Naume, et al.. (2013). 18F-FDG PET : Changes in uptake as a method to assess radium-223 dichloride (Ra-223) response in bone metastases of breast cancer patients with bone-dominant disease. Open Repository and Bibliography (University of Liège). 1 indexed citations

15.

Synnestvedt, Marit, Elin Borgen, Erik Wist, et al.. (2012). Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study. BMC Cancer. 12(1). 616–616. 18 indexed citations

16.

Janni, Wolfgang, Florian D. Vogl, Gro Wiedswang, et al.. (2011). Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis. Clinical Cancer Research. 17(9). 2967–2976. 192 indexed citations

17.

Glynn, Sharon A., Brenda J. Boersma, Tiffany M. Howe, et al.. (2009). A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide. Clinical Cancer Research. 15(12). 4165–4173. 38 indexed citations

18.

Naume, Bjørn, Xi Zhao, Marit Synnestvedt, et al.. (2007). Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Molecular Oncology. 1(2). 160–171. 113 indexed citations

19.

Nord, Silje, Fredrik Johansen, Grethe I.G. Alnæs, et al.. (2007). Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes. Breast Cancer Research. 9(6). 113–113. 35 indexed citations

20.

Naume, Bjørn, Elin Borgen, Klaus Beiske, et al.. (1997). Immunomagnetic Techniques for the Enrichment and Detection of Isolated Breast Carcinoma Cells in Bone Marrow and Peripheral Blood. Journal of Hematotherapy. 6(2). 103–114. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact